PL452-hGH-polyA-PGK-neoR Citations (1)

Originally described in: Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model.
Xu P, He H, Gao Q, Zhou Y, Wu Z, Zhang X, Sun L, Hu G, Guan Q, You Z, Zhang X, Zheng W, Xiong M, Chen Y J Clin Invest. 2022 Jul 15;132(14). pii: 156768. doi: 10.1172/JCI156768. PubMed Journal

---

Articles Citing PL452-hGH-polyA-PGK-neoR

Articles

3D-generation of high-purity midbrain dopaminergic progenitors and lineage-guided refinement of grafts supports Parkinson's disease cell therapy. Zhang X, Wu Z, He H, Guan Q, Ouyang Q, Wang R, Xie L, Zhou Y, Feng B, Luo Z, Xu P, Yan W, Hu G, Li J, Zhang M, Zou Y, Xu X, Zhou C, Cheng Q, Liu J, Gao Q, Yang S, Xiong M, Chen Y. Cell Stem Cell. 2025 Nov 6;32(11):1758-1772.e8. doi: 10.1016/j.stem.2025.10.001. Epub 2025 Oct 27. PubMed

If you have published an article using this material, please email us at to have your article added to this page.